Company Filing History:
6 out of 549 
1 out of 96 
Years Active: 2017-2025
Title: Innovations of Anjan Thakurta: Pioneering Hematological Treatments
Introduction
Anjan Thakurta, an innovative inventor based in Basking Ridge, NJ, has made significant contributions to the field of pharmaceutical sciences. With a portfolio of six patents, he is recognized for his work in developing novel compounds aimed at treating hematological malignancies. His groundbreaking inventions exemplify the intersection of chemistry and medicine, showcasing his commitment to advancing healthcare.
Latest Patents
Thakurta's most recent patents focus on "Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use." These patents describe methods utilizing (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione, along with various second active agents, to treat, prevent, or manage hematological malignancies. The second active agents include a range of inhibitors such as HDAC, BCL2, BTK, and several others, emphasizing his focus on innovative combinations of therapeutic agents to enhance treatment efficacy.
Career Highlights
Anjan Thakurta has established a distinguished career in the pharmaceutical industry, having worked with reputable companies like Celgene Corporation and Agios Pharmaceuticals, Inc. His experience in these institutions has endowed him with a practical understanding of drug development and innovation, allowing him to translate scientific challenges into viable solutions.
Collaborations
Throughout his professional journey, Thakurta has collaborated with notable colleagues, such as Michael D. Amatangelo and Chad Bjorklund. These partnerships have contributed to fostering an environment of creativity and innovation, enabling the development of advanced pharmaceutical solutions.
Conclusion
Anjan Thakurta stands out as a leading inventor in the realm of hematological treatments through his innovative patents and collaborative efforts. His dedication to improving patient outcomes through scientific advancement reflects his significant role in the ongoing evolution of medical treatments. With each patent, Thakurta continues to pave the way for future innovations in the pharmaceutical industry.